No headlines found.
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
Globe Newswire (Thu, 10-Oct 7:00 AM ET)
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
Globe Newswire (Fri, 27-Sep 6:57 AM ET)
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Globe Newswire (Thu, 12-Sep 6:57 AM ET)
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
Globe Newswire (Tue, 10-Sep 6:57 AM ET)
Globe Newswire (Thu, 5-Sep 6:57 AM ET)
Globe Newswire (Thu, 29-Aug 6:57 AM ET)
Globe Newswire (Wed, 21-Aug 7:57 AM ET)
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
Globe Newswire (Thu, 15-Aug 9:48 AM ET)
Aclarion Announces First Commercial Agreement in Michigan
Globe Newswire (Wed, 14-Aug 8:08 AM ET)
Globe Newswire (Tue, 13-Aug 9:07 AM ET)
Aclarion - Warrant trades on the stock market under the symbol ACONW.
As of November 8, 2024, ACONW stock price climbed to $0.03 with 100 million shares trading.
ACONW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
ACONW has underperformed the market in the last year with a price return of -32.8% while the SPY ETF gained +38.4%. ACONW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -29.2% and -6.9%, respectively, while the SPY returned +13.1% and +3.3%, respectively.
ACONW support price is $.02 and resistance is $.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACONW shares will trade within this expected range on the day.